Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Polyrizon Ltd. (“Polyrizon”), a privately held company in which Medigus owns 37.03%, has submitted a PCT (Patent Cooperation Treaty) application, following a submission to the United States Patent and Trademark Office for its innovative technology.
Incyte Announces Results From SCRATCH-AD Trial Demonstrating Substantial And Rapid Itch Reduction In Patients With Mild-Moderate Atopic Dermatitis Treated With Opzelura Cream
– Adult patients with atopic dermatitis treated with Opzelura experienced rapid and substantial improvement in itch, which was sustained through Day 28Incyte (NASDAQ:INCY) today announced new data from the Phase 2